位置:首页 > 蛋白库 > NLGN4_MOUSE
NLGN4_MOUSE
ID   NLGN4_MOUSE             Reviewed;         945 AA.
AC   B0F2B4; A7LAI9; B1P942;
DT   13-JUN-2012, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 1.
DT   03-AUG-2022, entry version 76.
DE   RecName: Full=Neuroligin 4-like;
DE   AltName: Full=Neuroligin-4;
DE            Short=NL-4;
DE   Flags: Precursor;
GN   Name=Nlgn4l; Synonyms=Nl4*, Nlgn4, Nlgn4x;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   STRAIN=C57BL/6J;
RX   PubMed=18227507; DOI=10.1073/pnas.0711555105;
RA   Jamain S., Radyushkin K., Hammerschmidt K., Granon S., Boretius S.,
RA   Varoqueaux F., Ramanantsoa N., Gallego J., Ronnenberg A., Winter D.,
RA   Frahm J., Fischer J., Bourgeron T., Ehrenreich H., Brose N.;
RT   "Reduced social interaction and ultrasonic communication in a mouse model
RT   of monogenic heritable autism.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:1710-1715(2008).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, INTERACTION WITH NRXN1,
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RC   STRAIN=129/Sv, and BALB/cJ; TISSUE=Brain;
RX   PubMed=18434543; DOI=10.1073/pnas.0801383105;
RA   Bolliger M.F., Pei J., Maxeiner S., Boucard A.A., Grishin N.V.,
RA   Sudhof T.C.;
RT   "Unusually rapid evolution of neuroligin-4 in mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:6421-6426(2008).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [4]
RP   FUNCTION, DISRUPTION PHENOTYPE, SUBCELLULAR LOCATION, INTERACTION WITH GPHN
RP   AND ARHGEF9, AND TISSUE SPECIFICITY.
RX   PubMed=21282647; DOI=10.1073/pnas.1006946108;
RA   Hoon M., Soykan T., Falkenburger B., Hammer M., Patrizi A., Schmidt K.F.,
RA   Sassoe-Pognetto M., Lowel S., Moser T., Taschenberger H., Brose N.,
RA   Varoqueaux F.;
RT   "Neuroligin-4 is localized to glycinergic postsynapses and regulates
RT   inhibition in the retina.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:3053-3058(2011).
CC   -!- FUNCTION: Cell surface protein involved in cell-cell-interactions.
CC       Plays a role in the formation or maintenance of synaptic junctions via
CC       its interactions (via the extracellular domains) with neurexin family
CC       members. Plays a role in synaptic signal transmission.
CC       {ECO:0000269|PubMed:18434543, ECO:0000269|PubMed:21282647}.
CC   -!- SUBUNIT: Homodimer. Interacts with NRXN1. Interacts with GPHN and
CC       ARHGEF9. {ECO:0000269|PubMed:18434543, ECO:0000269|PubMed:21282647}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Postsynaptic cell membrane. Note=Detected at glycinergic
CC       postsynapses in retina. Detected on dendritic spines on cultured
CC       neurons.
CC   -!- TISSUE SPECIFICITY: Detected in brain cortex, septum, hippocampus,
CC       striatum, olfactory bulb, retina, colliculi, brain stem, cerebellum,
CC       thymus and skeletal muscle. Detected at inhibitory synapses throughout
CC       the brain and spinal cord (at protein level). Detected in brain,
CC       spleen, lung, skeletal muscle and kidney. {ECO:0000269|PubMed:18227507,
CC       ECO:0000269|PubMed:18434543, ECO:0000269|PubMed:21282647}.
CC   -!- DISRUPTION PHENOTYPE: Mice are viable and fertile with no obvious
CC       sensory deficits or major perturbations of behavior, but show subtle
CC       changes in synaptic signal transmission and signal processing. Mice
CC       display subtle deficits in reciprocal social interactions and
CC       communication. They have reduced brain volume.
CC       {ECO:0000269|PubMed:18227507, ECO:0000269|PubMed:21282647}.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF694290; ABV59297.1; -; mRNA.
DR   EMBL; EF692521; ABS19580.1; -; mRNA.
DR   EMBL; EU350930; ACA64246.1; -; Genomic_DNA.
DR   AlphaFoldDB; B0F2B4; -.
DR   SMR; B0F2B4; -.
DR   IntAct; B0F2B4; 1.
DR   ESTHER; mouse-4neur; Neuroligin.
DR   MEROPS; S09.994; -.
DR   SwissPalm; B0F2B4; -.
DR   MaxQB; B0F2B4; -.
DR   PeptideAtlas; B0F2B4; -.
DR   PRIDE; B0F2B4; -.
DR   ProteomicsDB; 293857; -.
DR   ABCD; B0F2B4; 2 sequenced antibodies.
DR   MGI; MGI:3775191; Nlgn4l.
DR   InParanoid; B0F2B4; -.
DR   PRO; PR:B0F2B4; -.
DR   Proteomes; UP000000589; Unplaced.
DR   RNAct; B0F2B4; protein.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0009986; C:cell surface; ISS:BHF-UCL.
DR   GO; GO:0030425; C:dendrite; ISS:BHF-UCL.
DR   GO; GO:0060076; C:excitatory synapse; ISS:BHF-UCL.
DR   GO; GO:0098690; C:glycinergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0099060; C:integral component of postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0045211; C:postsynaptic membrane; IC:BHF-UCL.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0045202; C:synapse; IDA:BHF-UCL.
DR   GO; GO:0031404; F:chloride ion binding; ISO:MGI.
DR   GO; GO:0042043; F:neurexin family protein binding; ISS:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:MGI.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0003360; P:brainstem development; IMP:BHF-UCL.
DR   GO; GO:0021549; P:cerebellum development; IMP:BHF-UCL.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0008049; P:male courtship behavior; IMP:BHF-UCL.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0090394; P:negative regulation of excitatory postsynaptic potential; ISS:BHF-UCL.
DR   GO; GO:0007158; P:neuron cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0035265; P:organ growth; IMP:BHF-UCL.
DR   GO; GO:0097104; P:postsynaptic membrane assembly; IBA:GO_Central.
DR   GO; GO:0097105; P:presynaptic membrane assembly; ISS:BHF-UCL.
DR   GO; GO:0035176; P:social behavior; IMP:BHF-UCL.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0002124; P:territorial aggressive behavior; IMP:BHF-UCL.
DR   GO; GO:0071625; P:vocalization behavior; IMP:BHF-UCL.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   Pfam; PF00135; COesterase; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Membrane; Postsynaptic cell membrane;
KW   Reference proteome; Signal; Synapse; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..945
FT                   /note="Neuroligin 4-like"
FT                   /id="PRO_0000417951"
FT   TOPO_DOM        19..761
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        762..782
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        783..945
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          145..167
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          685..742
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          787..828
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        147..161
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        715..742
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        93..129
FT                   /evidence="ECO:0000250"
FT   DISULFID        315..338
FT                   /evidence="ECO:0000250"
FT   DISULFID        527..583
FT                   /evidence="ECO:0000250"
FT   CONFLICT        5
FT                   /note="V -> A (in Ref. 2; ABS19580/ACA64246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        106
FT                   /note="C -> R (in Ref. 2; ABS19580/ACA64246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="T -> P (in Ref. 2; ACA64246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        154
FT                   /note="H -> P (in Ref. 2; ACA64246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        573
FT                   /note="H -> P (in Ref. 2; ABS19580/ACA64246)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        893
FT                   /note="T -> A (in Ref. 2; ABS19580/ACA64246)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   945 AA;  97348 MW;  03DFC91F1350ED6A CRC64;
     MPAPVPALLC LALALASAQP SPPPPPPFPV VATNYGKLRG VRAALPGDVL GPVTQFLGVP
     YAAPPTGERR FQPPEPPSSW AGVRDATRFA PVCPQHLDER ALLRDCLPAW FAANLDAIAA
     YVQDQSEDCL YLNLYVPGGA NGKKMADDVT GNDHGDDQDS RDPGVGGAAA AAARKPVMVY
     IHGGSYMEGT ANIVDGSVLA SYGDVIVVTV NYRLGVLGFL STGDQAAKGN YGLLDQIQAL
     RWVEENAGAF GGDPDRVTVF GSGAGASCVS LLTLSHYSEG LFQKAIIQSG TALSSWAVNY
     QPARYARALG ERVGCATPDP GSPPGSPPGW DSASLVSCLR GKAAGELARA RVTPATYHVA
     FGPTVDGDVI PDDPQILMEQ GEFLNYDIML GVNQGEGARF VDGLGGGHDG GYGGYGGGYG
     GGVEDDEVQD GGPDGAAGGV SAGEFDLAVS GFINDLYGRP EGRGDALRET VKFMYTDWAD
     RDSPEARRKT LVALFTDHQW VAPAVATADL HARYGSPTYF YAFYHRCHGG GGGGGGVDGV
     AGGVAGGVGG EEARPAWADA AHGDEVPYVF GVHMAGPGDV FGCNFSRNDV MLSAVVMTYW
     TNFAKTGDPN QPVAQDTRFV HTRPNRFEEV AWAKYDPRGQ LYLHIGLRPR VRDHYRAAKV
     AFWLELVPHL HGLAADPGAY LSAAATRAAP SGDPDRDPGG GGGGRRRPRP ATRRPAVMTS
     SSMASGSGMT SSSGSGMTSS SGSSASAVLI ETRRDYSTEL SVTIAVGASL LFLNVLAFAA
     LYYKKDKRRH ETHRRPPPPR PPQAPPSAAA ADRNPRPDPG PAGRRGGECG AVVTAMAAEA
     SAGGLGHDGV GGVGVGGVIG GVAGLRLACP PDYALTLRRS PDDVPRAGAG PGTMTLIPGA
     LGGGGGGAVH GFNTFGSGVG VAGVAGVATS QAGPGLPHGH STTRV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024